Tag Archives: chemotherapy

A New Method to Treat Chemotherapy-Induced Neuropathic Pain

Posted on March 12, 2012 by wngai

If you are cancer patients and have to receive chemotherapy agents such as taxanes (paclitaxol- Taxol and docetaxel-Taxotere), vinca alkaloids (vinorelbine-Navelbine) and platinum compounds (cisplatin, carboplatin – Paraplatin and oxaliplatin – Eloxatin), it is likely that you might experience chemotherapy … Continue reading →

Which is Best Chemotherapy Option for Advanced Bladder Cancer?

Posted on May 15, 2011 by wngai

Transitional cell or urothelial carcinoma is the most common type of bladder cancer, accounting for more than 90% all bladder cancers. This type of cancer is sensitive to treatment with chemotherapeutic agents. This type of cancer is usually treated with … Continue reading →

Posted in Bladder Cancer, Cancer | Tagged advanced bladder cancer, carboplatin, chemotherapy, Cisplatin, doxorubicin, gemcitabine, methotreaxate, MVAC, Transitional cell carcinoma, urothelial carcinoma, vinblastine | Comments Off

New Treatment for Colorectal Cancer Patients with Liver Metastases

Posted on April 3, 2011 by wngai

In the past, bevacizumab (Avastin) plus FOLFOX (leucovorin, 5-fluorouracil, and oxaliplatin) is the mainstay treatment for colorectal cancer patients with metastases (Stage IV). Even though the response rate of this regimen is impressive, less than 10% of Stage IV colorectal cancer … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged 5-Fluorouracil, Avastin, bevacizumab, chemotherapy, FOLFOX, leucovorin, metastatic colorectal cancer, oxaliplatin, radiofrequency ablation, RFA, Survival | Comments Off

Fish Oil Prevents Weight and Muscle Loss in Cancer Patients

Posted on March 6, 2011 by wngai

Cancer patients who are taking chemotherapy are always worried about muscle wasting (cachexia) and weight loss. Now, a small study suggests that supplementation with fish oil might prevent muscle wasting (cachexia) and weight loss. In the study, investigators randomized 40 … Continue reading →

Posted in Alternative Medicine, Cancer | Tagged Cachexia, Cancer, chemotherapy, Fish oil, malnutrition, muscle wasting, Prevent+, Weight loss | Comments Off

Anorexia and Cachexia – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment

Posted on November 27, 2010 by wngai

Anorexia in Cancer Cancer anorexia-cachexia syndrome (CACS) is an extremely common condition in cancer patients. It is estimated that 50% of cancer patients suffered from anorexia. The exact frequency of CACS varies according to the primary pathology (from 30% in … Continue reading →

Posted in Cancer, Gastric Cancer, Others, Pancreatic Cancer | Tagged AIDS, Anorexia, Bristol-Myers Squibb, Cachexia, Causes, chemotherapy, cyprohetadine, Diagnosis, dronabinol, Gastric Cancer, Lymphoma, malnutrition, Marinol, Megace, megestrol, Merck, Metastatic breast cancer, orexigenic, Oxandrin, oxandrolone, Pancreatic Cancer, Periactin, Prognosis, Symptoms, Treatment, Unimed, wasting | 2 Comments

FDA Approves Halaven for Late-Stage Breast Cancer

Posted on November 22, 2010 by wngai

Good news for patients with late stage metastatic breast cancer. The US Food and Drug Administration (FDA) approved eribulin mesylate injection (Halaven; Eisai, Inc) for the treatment of metastatic breast cancer in patients who have received at least 2 prior … Continue reading →

Posted in Breast cancer, Cancer | Tagged anthracycline, Bristol-Myers Squibb, capecitabine, chemotherapy, Eisai, eribulin, Halaven, ixabepilone, Ixempra, Metastatic breast cancer, paclitaxel, resistant, Roche, Survival, taxane, Xeloda | Comments Off

A New Treatment Option for patients with Gastric Cancer

Posted on September 12, 2010 by wngai

Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide. Previous study has found that patients with operable disease have a 5-year survival rate of 36%. In patients with advanced or … Continue reading →

Posted in Cancer, Gastric Cancer | Tagged 5-Fluorouracil, capecitabine, chemotherapy, Cisplatin, Gastric Cancer, Gastro-esophageal Junction Cancer, Herceptin, Survival, Trastuzumab, Xeloda | Comments Off

Yunzhi-Danzhen Improves Immune System in Nasopharyngeal Cancer(NPC) Patients

Posted on September 12, 2010 by wngai

Nasopharyngeal carcinoma is a prevalent tumor in Hong Kong. If you have nasopharyngeal cancer, that is a bad news. The good news is patients with early stage disease (Stage I and II disease) have a 5-year survival rate of more than 70%. … Continue reading →

Posted in Alternative Medicine, Cancer, Herbal Medicine, Nasopharyngeal Cancer | Tagged chemotherapy, chemotherapy side-effects, Coriolus versicolor, Danzhen, Herbal Medicine, Herbal Medicine, Immune system, Nasopharyngeal Cancer, Salvia miltiorrhiza, Yunzhi | Comments Off

Ancient Chinese Herbal Medicine Reduces Side-Effects of Chemotherapy

Posted on August 22, 2010 by wngai

A Chinese herbal formula that was used more than 1,800 years ago was shown to reduce the gastrointestinal side effects of chemotherapy but also increased its efficacy in mice, according to a study published in the August issue of the … Continue reading →

Posted in Cancer, Colorectal cancer, Herbal Medicine | Tagged camptosar, chemotherapy, Chinese herbal medicine, colorectal cancer, efficacy, Herbal Medicine, Herbal Medicine, Huang Qin Tang, Irinotecan, jujube, licorice, peony, side-effects, skullcap | 3 Comments

New Chemotherapy, Cabazitaxel (Jevtana), for Advanced Prostate Cancer

Posted on July 4, 2010 by wngai

A new chemotherapy, Cabazitaxel (Jevtana) has been approved in the United States to treat men who have advanced hormone-refractory prostate cancer and have failed docetaxel. The approval was based on the results of the phase 3 TROPIC clinical study, which … Continue reading →

Posted in Cancer, Prostate cancer | Tagged cabazitaxel, chemotherapy, hormone refractory, Jevtana, mitoxantrone, Prostate cancer, Survival, TROPIC | Comments Off